| 000 | 01889 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517105116.0 | ||
| 264 | 0 | _c20170207 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2016.07.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNooshinfar, Elaheh | |
| 245 | 0 | 0 |
_aMelatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cOct 2016 |
||
| 300 |
_a456-465 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xgenetics |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aMelatonin _xpharmacology |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
| 650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
| 650 | 0 | 4 | _aSurvivin |
| 650 | 0 | 4 |
_aTelomerase _xgenetics |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aBashash, Davood | |
| 700 | 1 | _aSafaroghli-Azar, Ava | |
| 700 | 1 | _aBayati, Samaneh | |
| 700 | 1 | _aRezaei-Tavirani, Mostafa | |
| 700 | 1 | _aGhaffari, Seyed H | |
| 700 | 1 | _aAkbari, Mohammad Esmaeil | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 83 _gp. 456-465 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2016.07.004 _zAvailable from publisher's website |
| 999 |
_c26237042 _d26237042 |
||